Kamal Adawi is Chief Financial Officer of FATE THERAPEUTICS INC. Currently has a direct ownership of 75,000 shares of FATE, which is worth approximately $115,500. The most recent transaction as insider was on Oct 20, 2025, when has been sold 75,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 75K
n/a 3M change
n/a 12M change
Total Value Held $115,500

Kamal Adawi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 20 2025
BUY
Grant, award, or other acquisition
-
75,000 Added 50.0%
75,000 Common Stock

Also insider at

XGN
EXAGEN INC. Healthcare
KA

Kamal Adawi

Chief Financial Officer
Vista, CA

Track Institutional and Insider Activities on FATE

Follow FATE THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FATE shares.

Notify only if

Insider Trading

Get notified when an Fate Therapeutics Inc insider buys or sells FATE shares.

Notify only if

News

Receive news related to FATE THERAPEUTICS INC

Track Activities on FATE